APA
Ahmed O. A., Kaisar H. H., Badawi R., Hawash N., Samir H., Shabana S. S., Fouad M. H. A., Rizk F. H., Khodeir S. A. & Abd-Elsalam S. (2018). Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection. : Infection and drug resistance.
Chicago
Ahmed Ossama A, Kaisar Hany H, Badawi Rehab, Hawash Nehad, Samir Hossam, Shabana Sherif St, Fouad Mohamed Hassan A, Rizk Fatma H, Khodeir Samy A and Abd-Elsalam Sherief. 2018. Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection. : Infection and drug resistance.
Harvard
Ahmed O. A., Kaisar H. H., Badawi R., Hawash N., Samir H., Shabana S. S., Fouad M. H. A., Rizk F. H., Khodeir S. A. and Abd-Elsalam S. (2018). Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection. : Infection and drug resistance.
MLA
Ahmed Ossama A, Kaisar Hany H, Badawi Rehab, Hawash Nehad, Samir Hossam, Shabana Sherif St, Fouad Mohamed Hassan A, Rizk Fatma H, Khodeir Samy A and Abd-Elsalam Sherief. Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection. : Infection and drug resistance. 2018.